Published in Blood Weekly, November 6th, 2008
The Series C financing complements the Company's Series B financing that was completed earlier this year. The Series B was lead by private investors. Together, these two financings are expected to result in $9M of new capital being infused into Micronics.
"Micronics is poised to advance a new class of clinical diagnostic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.